Your browser does not support JavaScript
For Practitioners
 

Practitioners


Has your patient had a history of hyperoxaluria (HOx) due to an underlying malabsorptive gastrointestional condition (e.g., bariatric surgery, Crohn’s disease, short bowel syndrome, or other malabsorption disorders)?

If YES, your patient may be eligible for the uriROX-2 clinical research study.

uriROX-2

 
  PRIVACY POLICY | TERMS OF USE
© 2021 Allena Pharmaceuticals, Inc. All rights reserved.